Background {#Sec1}
==========

Subarachnoid hemorrhage (SAH), mainly caused by a ruptured intracranial aneurysm, remains a prominent clinical problem with a high rate of mortality and morbidity worldwide \[[@CR1], [@CR2]\]. Despite great efforts that have been made into the treatment of SAH, the prognosis of patients with SAH remains unsatisfactory. Therefore, it is important to further explore and gain a deeper understanding of the underlying pathological mechanisms of SAH to develop novel therapeutic strategies for patients with SAH.

Inflammatory response, characterized by the activation of immune cells and release of multiple chemokines, is a fundamental response to maintain the central nervous system (CNS) homeostasis \[[@CR3], [@CR4]\]. However, excessive or prolonged neuroinflammation is potentially harmful and can lead to neuronal damage and neurological dysfunction in both acute and chronic CNS diseases including SAH \[[@CR5]--[@CR7]\]. Microglia is the resident immune cell distributed in CNS. Generally, microglia keep in a resting status (M0), characterized by a small soma, long protrusions, and rod-shaped nuclei, and functions in immune surveillance. Upon activated by pathogens, however, microglia can rapidly change morphology (with a bigger soma, shorter protrusions, and amoeboid morphology) and migrate to the site of injury to mediate inflammation. The activated microglia can be transformed into two different phenotypes (M1 and M2) with distinct physiological functions in responses to different stimulators \[[@CR8]\]. M1 microglia, which are usually activated by immune receptors including toll-like receptors (TLRs), and nucleotide-binding oligomerization domains (NODs), can recognize and respond to pathogens by secreting pro-inflammatory cytokines and chemokines (such as IL-1β and TNFα), ultimately elevating the immune response and exacerbating brain damage \[[@CR9], [@CR10]\]. In contrast to the pro-inflammatory M1 phenotype, M2 microglia have been proved to mediate neuroprotective effects via producing anti-inflammatory cytokines such as IL-10 and promoting tissue repair and angiogenesis \[[@CR11], [@CR12]\]. Evidence above suggests that suppressing prolonged neuroinflammation via inhibiting the M1 phenotype and/or promoting the M2 phenotype might be an effective and promising therapeutic strategy for SAH as well.

Stimulator of interferon genes (STING) is a cytosolic DNA sensor wildly distributed in mammalian immune cells, including DC cell, T cells, and macrophage, that functions as an important mediator to regulate innate immune response \[[@CR13]\]. Generally, cyclic GMP-AMP synthase (cGAS) catalyzes cytosolic DNA including the foreign double-stranded DNA (dsDNA) derived from pathogens and endogenous chromosomal fragments leakaged from mitochondria into cyclic GMP-AMP (cGAMP). The cGAMP further acts as a second messenger to activate STING and drives STING translocation from endoplasmic reticulum (ER) into perinuclear microsome via the Golgi apparatus[.]{.ul} Subsequently, activated STING recruits and phosphorylates TANK-binding kinase 1 (TBK1), which further active Interferon regulatory factor 3 (IRF3), ultimately upregulating the expression of type I IFN and enhancing inflammatory response through recruiting and activating immune cells \[[@CR14]\]. The activation of STING confers to the host immunity and plays a critical role in removing multiple pathogens including both viruses and bacteria \[[@CR15]--[@CR17]\]. Meanwhile, uncontrolled and excessive STING activation has been identified to contribute to the progression of autoinflammatory diseases \[[@CR18], [@CR19]\]. Although the critical and complex role of STING in regulating immune response, which is both detrimental and protective, has been studied for decades, the precise role of STING in the pathological process following SAH has not been clarified.

Based on the evidence above, we hypothesized that STING might be an important regulator of SAH-induced neuroinflammation. The SAH models, both in vivo and in vitro, were introduced to determine the role of STING under SAH condition and to further investigate the relevant mechanisms.

Methods {#Sec2}
=======

Animals and ethical statement {#Sec3}
-----------------------------

All procedures involved animals were conformed to the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health and were approved by the Institutional Animal Care and Use Committee of Zhejiang University. Male C57BL/6 J mice (body weight 20-25 g) were purchased from Slac Laboratory Animal Co., Ltd. (Shanghai, China) and were kept at room temperature (22 ± 1 °C) and in a 12 h day/night cycle (humidity: 60 ± 5%). Animals were free to access to food and water.

Surgical procedures {#Sec4}
-------------------

The SAH model was established via endovascular perforation as previously described \[[@CR20]\]. Briefly, C57BL/6 J mice were anesthetized with 1% pentobarbital (50 mg/kg, i.p.) and left carotid artery and its branches were exposed. Then, a sharped nylon suture was inserted from the external carotid artery and further went along into the internal carotid artery, ultimately perforated the bifurcation of the anterior and middle cerebral arteries. Mice in the sham group underwent the same procedure except for the suture was withdrawn without puncture.

Experimental design {#Sec5}
-------------------

This study was completed in four separate experiments (as shown in Fig. [1](#Fig1){ref-type="fig"}). A total of 344 mice including the dead ones, were used in this study. Fig. 1Experimental design and animal groups

### Experiment 1 {#Sec6}

To determine the expression pattern and distribution of STING after SAH, mice were randomly divided into sham group and SAH groups with different time points (3 h, 6 h, 12 h, 24 h, 48 h, and 72 h). The ipsilateral cerebral cortex from each group was harvested for western blotting (*n* = 6). In addition, the cellular location of STING was assessed using double immunofluorescence staining in sham and SAH (24 h) groups (*n* = 6).

### Experiment 2 {#Sec7}

To explore the effect of STING in the pathological process after SAH, the selective STING antagonist C-176 and STING agonist CMA were used. Mice were randomly divided into six groups: sham group, SAH + vehicle group, SAH + C-176 group, and SAH + CMA group. Brain water content (*n* = 6), western blotting (*n* = 6), and quantitative real-time PCR (*n* = 6) were performed at 24 h after SAH conduction. Moreover, neurological function was tested at 24 h (*n* = 24), 72 h (*n* = 10), or 28 days (*n* = 10) after SAH separately. And immunofluorescence staining and Nissl staining (*n* = 6) were carried out at 24 h and 28 days after SAH. Additionally, 24 mice were randomly divided into the sham+C-176 group and sham+CMA group (12 for each group), and neurological function was tested at 24 h post-modeling (*n* = 12), and the brain samples from these two groups were collected to assay the brain water content (*n* = 6) and western blotting (*n* = 6) at 24 h post-modeling. The sham group received the same volume of vehicle (corn oil) intraperitoneally at the same time points after SAH induction.

### Experiment 3 {#Sec8}

To further investigate the mechanisms of STING-mediated inflammation under SAH condition, compound C, a selective inhibitor of AMPK signal was introduced. Mice were divided into sham group, SAH + vehicle1 (corn oil) group, SAH + C-176 group, SAH + C-176 + vehicle2 (5%DMSO) group, and SAH + C-176 + compound C group. Western blotting (*n* = 6), quantitative real-time PCR (*n* = 6), immunofluorescence staining (*n* = 6), and behavioral test (*n* = 18) were performed at 24 h post-modeling. The sham group received the same volume of vehicle1 (corn oil) intraperitoneally at the same time points after SAH induction.

### Experiment 4 {#Sec9}

An in vitro SAH model was introduced to further study the effect and mechanism of STING after SAH. The cultured BV2 cell was incubated with oxygenated hemoglobin (OxyHb) to simulate SAH injury. Cells were assigned into different groups as follows: control group, control+CMA group, control+C-176 group, OxyHb+vehicle group, OxyHb+C-176 group, and OxyHb+C-176 + compound C group. Western blotting and quantitative real-time PCR (*n* = 6) were conducted during the study.

Drug administration {#Sec10}
-------------------

The STING antagonist C-176 (purchased from MedChemExpress, New Jersey, USA) that had been dissolved in 200 μL of corn oil (Sigma-Aldrich, MO, USA) with a final concentration at 750 nmol, were injected intraperitoneally at 30 min post-modeling. And the STING agonist CMA (purchased from Sigma-Aldrich, MO, USA) was dissolved in corn oil, and 225 mg/kg of CMA was intraperitoneally administrated at 1 h after surgery. The dosage and time points of C-176 and CMA were based on a previous study \[[@CR21]\]. The selective AMPK inhibitor compound C (MedChemExpress, USA) was dissolved in 5% dimethyl sulfoxide (DMSO) was injected into, and compound C (5 μg/5 μL) was injected into intracerebroventricular at 30 min before surgery as previously reported \[[@CR22]\].

Intracerebroventricular injection {#Sec11}
---------------------------------

Intracerebroventricular administration was performed as previously described \[[@CR22]\]. Briefly, a 27 gauge needle of a 10 μl Hamilton syringe was inserted into the left lateral ventricle through a small cranial burr hole was drilled into the skull according to the relative to bregma: 0.3 mm posterior, 1.0 mm lateral, and 2.5 mm deep. A microinfusion pump (Hamilton, Switzerland) was used for intracerebroventricular administration at a rate of 0.667 μl/min. The syringe was left in situ for an additional 10 min after infusion and then slowly removed. And the burr hole was sealed with bone wax.

SAH grade {#Sec12}
---------

The severity of SAH was evaluated according to the SAH grade scale as previously described \[[@CR23]\]. Briefly, the basal cistern was divided into six segments, and each segment was scored from 0 to 3 based on the amount of bleeding. A total score ranging from 0 to 18 was obtained by adding the scores together. All the tests and SAH grades were evaluated by an independent researcher.

Short-term and long-term behavioral analysis {#Sec13}
--------------------------------------------

All the neurological performance was evaluated by a blinded investigator. A modified Garcia scoring system was introduced to evaluate the short-term neurological deficits at 24 h and 72 h after modeling as previously describe \[[@CR24]\]. Spontaneous activity, symmetry of limbs, forelimb extension, climbing, body proprioception, and reaction to vibrissae were tested and scored from 0 to 3 for each segment. A higher score in the modified Garcia scoring system indicated a better neurological function.

Another neurobehavioral test was introduced to evaluate short-term neurobehavior as reported \[[@CR25]\]. Briefly, three activity examinations appetite, activity, and deficits were evaluated at 24 h and 72 h after modeling. Grading of neurologic deficits was as follows: severe neurologic deficit (score = 4 to 6), moderate neurologic deficit (score = 2 to 3), mild neurologic deficit (score = 1), and no neurologic deficit (score = 0). A lower score indicated a better neurological function.

Moreover, Morris water maze (MWM) test was conducted to test persistent cognitive impairments from 22 to 28 days post-modeling as previously described \[[@CR26]\]. At the beginning of MWM, animals were trained to find the escape platform with cues. Subsequently, the mice were trained to find the platform in four trials per day for 5 consecutive days. Mice would be manually guided to the platform if they could not to reach the platform within 60 s. [Ultimat](http://www.baidu.com/link?url=qtrSwgbqMDQ9WJoDMNpvE6roAMULzX1v0827mz2ZA4wa2jcUyiBgUy6DopFqPu3VRCqygVy88mHTfK_IBv7WeqNmdiXVRQomYUhjzKgo6KK)ely, the platform was removed to perform probe trial, and each subject was allowed to search the platform for 60 s. Escape latency, swimming distance, platform crossovers as well as the time spent in the target quadrant were tracked and analyzed with the SMART software (Panlab, USA).

Brain water content {#Sec14}
-------------------

Brain water content was tested to evaluate the severity of brain edema. Mice were sacrificed at 24 h after modeling and the brains were quickly removed and divided into the left hemisphere, right hemisphere, cerebellum, and brain stem. Each part was weighed immediately to get the wet weight. Then, the samples were dried at 105 °C for 72 h to get the dry weight. The brain water content was calculated as \[(wet weight − dry weight)/(wet weight)\] × 100%.

Immunofluorescence staining {#Sec15}
---------------------------

Immunofluorescence staining was conducted as previously described \[[@CR27]\]. Mice were anesthetized and perfused with 0.1 M PBS followed by 4% paraformaldehyde (PFA) (pH 7.4). Brain samples were collected and immersed in 4% PFA for 24 h and then transferred into 30% sucrose solution until dehydration. The sample was cut into 8 μm frozen coronal sections for immunofluorescence staining and Nissl staining. For immunofluorescence staining, brain slices were washed with PBS and then incubated with 5% donkey serum for 2 h at room temperature. Sections were incubated overnight at 4 °C with rabbit anti-STING (1:500, Proteintech, cat. No. 19851-1-AP), mouse anti--NeuN (1:500, Abcam, ab-104224), goat anti--Iba-1 (1:500, Abcam, ab-5076), mouse anti--GFAP protein (1:500, Abcam, ab10062), rabbit anti-iNOS (1:500, Proteintech, [Cat.No.](http://www.ptgcn.com/products/ISYNA1-Antibody-14142-1-AP.htm) 18985-1-AP), rabbit anti-IL-1β (1:200, Abcam, ab-9722), and goat anti-caspase-1 (1:200, Santa Cruz, sc-22165). After washing with PBS, the slides were incubated for 2 h at room temperature with secondary antibodies. To detect the neuronal death, terminal deoxynucleotide transferase deoxyuridine triphosphate (dUTP) nick end labeling (TUNEL) staining was performed according to the manufacturer's protocol (Roche Inc., Basel, Switzerland). Each mouse had 4 brain slides examined, and each slide was examined under 3 fields of vision to acquire the mean number of target cells using a fluorescence microscope (Olympus, Tokyo, Japan). Photomicrographs were saved and merged by the Image-Pro Plus software (Olympus, Melville, NY). The result of TNUEL staining was evaluated by an apoptotic index, which was calculated as (average number of TUNEL-positive neurons/total number of neurons) × 100%.

Nissl staining and hematoxylin and eosin staining {#Sec16}
-------------------------------------------------

The frozen brain slides used for Nissl staining and hematoxylin and eosin (HE) staining were prepared in the same way as those used to immunofluorescence staining. Nissl staining was conducted to demonstrate the number of normal neuron in cortex and hippocampus as previously reported \[[@CR28]\]. The frozen brain slides were immersed with 0.5% cresyl violet (Sigma-Aldrich, St. Louis, MO, USA) solution and dehydrated with 100% alcohol. Hematoxylin and eosin (HE) staining was performed using a HE Staining Kit (C0105; Beyotime Institute of Biotechnology, Haimen, China) to determine the morphological change. After sealed with neutral balsam, the slides were observed under a light microscope (DM2500; Carl Zeiss) by a blinded investigator.

Cell culture and in vitro SAH model {#Sec17}
-----------------------------------

Murine BV2 cells were cultured in a DEME medium (Gibco, USA) with 10% fetal bovine serum (Gibco, USA) and 1% penicillin/streptomycin (Gibco, USA) in the atmosphere containing 5% carbon dioxide at 37 °C. Oxygenated hemoglobin (OxyHb, 10 μM, Sigma-Aldrich, USA) was introduced into the medium for 24 h to simulate SAH insult in vitro as previously described \[[@CR29]\]. After incubation, the medium was removed and cells were washed with PBS (0.01 M, pH 7.40) before further studies. To determine the effect and mechanism of STING following SAH, BV2 cells were pretreated with 250 μg/ml CMA, 0.5 μM C-176, or/and 10 μM compound C for 1 h before OxyHb incubation \[[@CR21], [@CR30]\].

Cell viability {#Sec18}
--------------

Cell viability was evaluated using a CCK-8 kit (Dojindo, Japan). BV2 cells were seeded in 96-well plates, and SAH stimulation was conducted as described above. Subsequently, 10 μL of CCK-8 solution was added into each well and incubated for 2 h. The OD value was measured with a microplate reader (BioTek, USA) at 450 nm. The results are expressed as the percentage of viable cells, and cell viability in the control group was considered to be 100% viability.

Western blotting {#Sec19}
----------------

Western blotting was conducted as previously described \[[@CR31]\]. Proteins from brain samples and cultured BV2 cells were lysed using RIPA lysis buffer. Equal amounts of protein (40 μg/10 μL) were loaded onto sodium dodecyl sulfate--polyacrylamide gels. The proteins were electrophoresed until sufficiently separated and then transferred to PVDF membranes. The membranes were incubated overnight at 4 °C with primary antibodies against rabbit anti-STING (1:1000, Proteintech, [Cat.No.](http://www.ptgcn.com/products/ISYNA1-Antibody-14142-1-AP.htm)[19851-1-AP](http://www.ptgcn.com/products/TMEM173-Antibody-19851-1-AP.htm)), rabbit anti-TBK1 (1:1000, Proteintech, [Cat.No.](http://www.ptgcn.com/products/ISYNA1-Antibody-14142-1-AP.htm) 28397-1-AP), rabbit anti-TBK1 (phospho S172) (1:2000, Abcam, ab-109272), rabbit anti-AMPK (phospho T183 and T172) (1:1000, Abcam, ab-23875), rabbit anti-AMPK (1:1000, Abcam, ab-80039), rabbit anti- iNOS (1:500, Proteintech, [Cat.No.](http://www.ptgcn.com/products/ISYNA1-Antibody-14142-1-AP.htm) 18985-1-AP), rabbit anti-IL-1β (1:1000, Abcam, ab-9722), rabbit anti-NLRP3(1:1000, Abcam, ab210491), mouse anti-ASC (1:2000, Santa Cruz, sc-271054), goat anti-caspase-1 (1:2000, Santa Cruz, sc-22165), and mouse anti-β-actin (1:5000, Proteintech, [Cat.No.](http://www.ptgcn.com/products/ISYNA1-Antibody-14142-1-AP.htm) 60008-1-Ig). The membranes were processed with horseradish-peroxidase-conjugated secondary antibodies at room temperature for 1 h. Bands were visualized using the ECL Plus chemiluminescence reagent kit (Amersham Bioscience, Arlington Heights, IL). The band densities were quantified with the Image J software (NIH).

Quantitative real-time PCR {#Sec20}
--------------------------

Quantitative real-time PCR was conducted as previously described \[[@CR9]\]. Total RNA was extracted from left cortical tissue or cultured BV2 cells using TRIzol reagent (Invitrogen, USA) and quantified by NanoDrop (Thermo Fisher, USA). Subsequently, total RNA was reverse transcribed into cDNA with the RevertAid First Strand cDNA Synthesis Kit (Thermo Fisher Scientific, USA). Then quantitative real-time PCR was performed with UltraSYBR Mixture (CWBio, China), specific mouse primers (listed in Supplementary Table S[1](#MOESM1){ref-type="media"}) and cDNA using the Mx3000P real-time PCR system (Agilent Technologies, USA). The mRNA expression of GAPDH was set as internal control. The results were expressed as fold changes compared with the sham group.

Statistical analysis {#Sec21}
--------------------

Data were shown as the mean ± standard deviation (SD). For the data meeting, normal distribution and homogeneity of variance, differences among the groups were analyzed using one-way analysis of variance (ANOVA) followed by Tukey's multiple comparison test. For the non-normal distribution and unequal variance parameters, Kruskal-Wallis test was used to compare differences among the groups and a Dunn-Bonferroni test for post hoc comparisons. Chi-square test was introduced for mortality comparison. Two-way repeated-measures ANOVA followed by Tukey's post hoc test was used to analyze the persistent neurological functions. Data were represented as mean ± standard deviation (SD). All statistical analyses were performed by SPSS (version 22.0), and statistical significance was determined as *P* \< 0.05.

Results {#Sec22}
=======

Physiological data and mortality {#Sec23}
--------------------------------

Physiological parameters including mean arterial pressure, arterial pH, PO~2~, PCO~2~, and blood glucose levels were monitored during the surgical procedure. And no significant changes in those physiological variables were noted among the different groups (Supplementary Table S[2](#MOESM2){ref-type="media"}). Moreover, none of the animals died in the sham group. There was no significant difference in mortality among the modeling groups (Supplementary Table S[2](#MOESM2){ref-type="media"}).

Temporal patterns and localization of STING after SAH {#Sec24}
-----------------------------------------------------

Western blotting results demonstrated that the level of STING was significantly increased at 12 h post-modeling and peaked at 24 h, after which the expression of STING gradually declined (Fig. [2](#Fig2){ref-type="fig"}a and b). Consistently, immunofluorescence staining confirmed the increased STING expression at 24 h after SAH. Furthermore, immunofluorescence staining indicated that STING was mainly located in microglia, rather than neurons or astrocytes (Fig. [2](#Fig2){ref-type="fig"}c-e, Supplementary Figure S[1](#MOESM3){ref-type="media"}). Fig. 2Expression and distribution of STING after SAH. **a**, **b** Representative western blotting images and quantitative analyses of STING expression in ipsilateral basal cortex after SAH. *n* = 6. The bars represent the mean ± SD. \**P* \< 0.05 versus sham. **c**, **d** Representative microphotographs of immunofluorescence double staining showing the localization of STING (red) with NeuN, GFAP, and Iba-1 (green) in sham group and SAH 24 h group. Scale bar = 50 μm

Effect of STING on short-term neurological function after SAH {#Sec25}
-------------------------------------------------------------

To investigate the potential role of STING in the pathological process after SAH, the selective STING antagonist C-176 and STING agonist CMA were introduced. Given that TBK1 is the direct downstream substrate of STING, and TBK1 can be phosphorylated and activated by STING, the level of TBK1 phosphorylation was examined to determine the efficacy of C-176 and CMA in inhibiting or activating STING in the brain under SAH condition, respectively. Western blotting indicated that the level of TBK1 phosphorylation was significantly increased after SAH (Fig. [3](#Fig3){ref-type="fig"}a), which was consistent with the upregulated level of STING (as shown in Fig. [2](#Fig2){ref-type="fig"}). Additionally, compared with SAH + vehicle group, the phosphorylation of TBK1 was remarkably inhibited by C-176, while CMA remarkably upregulated TBK1 phosphorylation (Fig. [3](#Fig3){ref-type="fig"}a). These results indicated that both C-176 and CMA could inhibit or activate STING signal in the brain effectively under SAH condition. Fig. 3Effect of STING on brain edema and short-term neurological function. **a** Representative picture and quantitative analysis of phosphorylation level of TBK1, the direct substrate of STING, in different groups. *n* = 6. **b** Quantification of SAH grade. *n* = 24. **c** Representative HE staining images of brain slides. No identifiable morphologic differences between sham-treated and SAH mice were noted under light microscope. Red circle shows the region of brain section collected for western blotting, immunofluorescence staining, and Nissl staining in cortex. *n* = 6. **d** Quantification of brain water content. *n* = 6. **e**-**g** Quantification of neurological function with two different scoring systems at 24 h (*n* = 24) and 72 h (*n* = 10) after SAH. Data are represented as mean ± SD. \**P* \< 0.05 versus sham group. \#*P* \< 0.05 versus SAH + vehicle group

When the animals were sacrificed and brain samples were collected, no significant difference in SAH grade among modeling groups was noted (Fig. [3](#Fig3){ref-type="fig"}b). Moreover, HE staining indicated that the surgical process did not cause identifiable morphological changes under light microscope (Fig. [3](#Fig3){ref-type="fig"}c). Brain edema is an independent risk factor for the poor prognosis of SAH. Compared with the sham group, mice in SAH + vehicle group demonstrated a significant increased brain water content at 24 h after and severe neurological dysfunction at both 24 h and 72 h after SAH (Fig. [3](#Fig3){ref-type="fig"}d-h). Moreover, blockade of STING with C-176 conferred a neuroprotective effect by reducing brain water content and attenuating neurological impairments (Fig. [3](#Fig3){ref-type="fig"}d-h). However, the STING agonist CMA further exacerbated brain edema and neurological dysfunction when compared with SAH + vehicle group (Fig. [3](#Fig3){ref-type="fig"}d-h). Notably, no significant differences in the level of TBK1 phosphorylation, brain water content or neurological function were observed in sham-operated mice that received C-176 or CMA when compared with mice in the sham group, suggesting the safety of C-176 and CMA in vivo (Supplementary Figure S[2](#MOESM4){ref-type="media"}).

Effect of STING in cortical neuronal injury {#Sec26}
-------------------------------------------

TUNEL staining and Nissl staining were performed to evaluate the effect of STING on cortical neuronal injury. When compared with the sham group, mice in SAH + vehicle group exhibited a significant increase in the neuronal apoptotic index and a decrease in the number of normal neurons (Fig. [4](#Fig4){ref-type="fig"}). In addition, pharmacological blockade of STING with C-176 remarkably inhibited neuronal apoptosis and increased the number of healthy neurons (Fig. [4](#Fig4){ref-type="fig"}). However, activation of STING with CMA exacerbated neuronal damage, as evidenced by the increased ratio of apoptotic cells and decreased the number of healthy neurons compared with those in SAH + vehicle group (Fig. [4](#Fig4){ref-type="fig"}). Fig. 4Effect of STING on cortical neuronal injury at 24 h after SAH. **a** Representative microphotograph showed the co-localization of TUNEL positive cell (green) with NeuN (red) in different groups. **b** Representative picture of Nissl staining in different group. **c**, **d** Quantitative analysis of TUNEL staining and Nissl staining. *n* = 6 for each group. Data was represented as mean ± SD. \**P* \< 0.05 versus sham group. \#*P* \< 0.05 versus SAH + vehicle group

Effect of STING on persistent neurological function and hippocampus injury {#Sec27}
--------------------------------------------------------------------------

In the next part of this study, Morris water maze (MWM) was introduced to evaluate the effect of STING on persistent cognitive impairment. Data from MWM indicated no significant difference in escape latency, swimming velocity, or swimming distance was noted on day 1, suggesting that there were no significant differences in swimming ability or visual impairment among animals at the baseline (Fig. [5](#Fig5){ref-type="fig"}a, b). However, compared with the sham group, mice in SAH + vehicle group demonstrated an increased escape latency and a longer swimming distance from day 2 to day 5 (Fig. [5](#Fig5){ref-type="fig"}a, b), suggesting a severe learning and memory impairment. And treat mice with C-176 conferred a better performance with decreased escape latency and shorter swimming distance on day 3 to day 5 compared with that in SAH + vehicle group (Fig. [5](#Fig5){ref-type="fig"}a, b). In addition, swimming trails suggested that mice in SAH + C-176 group demonstrated more crossovers and spent more time in the target quadrant (Fig. [5](#Fig5){ref-type="fig"}c-e). However, the administration of STING agonist CMA mediated a poorer performance in Morris water maze than that of mice in SAH + vehicle group (Fig. [5](#Fig5){ref-type="fig"}). Fig. 5Effect of STING on persistent neurobehavioral outcome after SAH. **a-c** Swimming velocity, escape latency, and swimming distance of Morris water maze. **d** The crossovers of the platform location in the probe quadrant. *n* = 10 per group. **e** Representative swimming trajectories of the different groups in probe trials. **f** The percentage of time spent in the probe quadrant. *n* = 10 per group. Data was represented as mean ± SD. \**P* \< 0.05 versus sham group. \#*P* \< 0.05 versus SAH + vehicle group

Hippocampus is an important brain region responsible for memory and learning. Therefore, we further evaluated the hippocampus injury using TUNEL staining and Nissl staining at 28 days post-modeling to gain a better understanding of the potential effect of STING on SAH-induced persistent neurological dysfunction. Compared with the sham group, mice in SAH + vehicle group demonstrated an increase in the ratio of TUNEL-positive neurons in DG region and a decrease in the number of normal neurons decreased in both CA1 and CA3 regions (Fig. [6](#Fig6){ref-type="fig"}). Treatment with C-176 significantly reduced the ratio of TUNEL-positive neurons and restored the number of normal neurons (Fig. [6](#Fig6){ref-type="fig"}). However, STING agonist CMA further exacerbated hippocampus injury when compared with that in SAH + vehicle group (Fig. [6](#Fig6){ref-type="fig"}). Overall, these data suggested that activation of STING contributed to persistent neurobehavioral impairment through mediating hippocampus injury after SAH. Fig. 6Effect of STING on hippocampus injury at 28 days after SAH. **a** Representative pictures showing Nissl staining of CA1 and CA3 regions. **b** Representative microphotographs showing the co-localization of TUNEL positive cells (green) with NeuN (red) in DG region. **c**, **d** The quantitative analysis of Nissl staining and TUNEL staining. *n* = 6 for each group. Data was represented as mean ± SD. \**P* \< 0.05 versus sham group. \#*P* \< 0.05 versus SAH + vehicle group

Effect of STING on neuroinflammation and microglial polarization {#Sec28}
----------------------------------------------------------------

Given the essential role of STING in innate immunity, the next part of this study was conducted to determine whether the adverse effects of STING in the pathological process following SAH were exerted through mediating neuroinflammatory response. Data from RT-PCR and western blotting indicated that the level of microglial M1 marker (CD16, IL-1β, iNOS, IL-6, TNF-α in mRNA, while iNOS, NLRP3, ASC, cleaved caspase1, and IL-1β in protein) were significantly increased after SAH (Fig. [7](#Fig7){ref-type="fig"}a-g), but the upregulation of these M1 markers was remarkably attenuated by C-176 (Fig. [7](#Fig7){ref-type="fig"}a-g). Additionally, compared with SAH + vehicle group, activation of STING with CMA further upregulated the level of these M1 markers (Fig. [7](#Fig7){ref-type="fig"}a-g). Fig. 7Effect of STING on SAH-induced neuroinflammation. **a**-**f** Representative western blotting images and quantitative analyses of iNOS, cleaved IL-1β, NLRP3, ASC, and caspase-1 p20 expression at 24 h after SAH. **g** Relative mRNA level of M1 microglia markers genes (CD16, iNOS, IL-1β, IL-6, TNF-α, and MCP-1). **h** Representative microphotographs demonstrated the morphological changes in microglia (Iba-1, green) and CD16 positive cells. Resting microglia are characterized by small soma, long protrusions, and rod-shaped nuclei (while arrows), while activated microglia are characterized by large soma, short protrusions, and amoeboid morphology (red arrows). **i**, **j** The quantitative analysis of morphological activated microglia and CD16-positive microglia. **k**, **l** Representative microphotographs and quantitative analysis of iNOS-positive cells (red). **m**-**o** Representative microphotographs and quantitative analysis of caspase-1-positive cells (red) and IL-1β-positive cell (green). *n* = 6 for each group. Data were represented as mean ± SD. \**P* \< 0.05 versus sham group. \#*P* \< 0.05 versus SAH + vehicle group

Moreover, immunofluorescence staining was used to further evaluate the activation and polarization of microglia. Microglia in the sham group were mainly kept in resting status (M0), morphologically noted with small soma and long protrusions in Iba-1 staining. In contrast, microglia in SAH + vehicle group were mostly transformed to adopt an activated status with bigger soma and short protrusions (Fig. [7](#Fig7){ref-type="fig"}h, i). In addition, CD16 staining further confirmed the microglial M1 polarization after SAH. The number of CD16-positive microglia increased after SAH (Fig. [7](#Fig7){ref-type="fig"}h, j). And treatment with C-176 significantly decreased the number of morphologically activated microglia and CD16-positive microglia (Fig. [7](#Fig7){ref-type="fig"}h, j). Furthermore, immunofluorescence staining indicated that the level of iNOS, caspase-1, and IL-1β was increased after SAH (Fig. [7](#Fig7){ref-type="fig"}k-o). Administration of C-176 significantly downregulated the level of these inflammatory mediators (Fig. [7](#Fig7){ref-type="fig"}k-o). However, activation STING with CMA significantly increased the number of morphologically activated microglia and CD16-positive microglia, as well as upregulated the level of M1 microglial markers (Fig. [7](#Fig7){ref-type="fig"}h-o). Evidences above suggested the critical role of STING in mediating neuroinflammation via promoting microglia activation and polarizing into M1 phenotype, and the STING antagonist C-176 could confer a robust anti-inflammatory effect under SAH condition.

AMPK signal is responsible for C-176-mediated anti-inflammatory effect {#Sec29}
----------------------------------------------------------------------

Activation of STING could suppress the activity of Adenosine monophosphate-activated protein kinase (AMPK), an important regulator of cellular metabolism and inflammation, in adipose tissue \[[@CR32]\]. Therefore, in the third part of this study, compound C, a selective inhibitor of AMPK was introduced to further determine the role of AMPK signal in C-176-mediated anti-inflammatory effects under SAH condition. Western blotting suggested an increased level of AMPK phosphorylation after SAH, and pharmacological inhibition of STING by C-176 significantly enhanced AMPK phosphorylation (Fig. [8](#Fig8){ref-type="fig"}a-g). In addition, compound C treatment significantly inhibited the phosphorylation level of AMPK, while it did not change the ratio of p-TBK1/TBK1 (Fig. [8](#Fig8){ref-type="fig"}a-g). Meanwhile, both western blotting and RT-PCR indicated that blockade of AMPK with compound C significantly upregulated the level of microglial M1 markers when compared with SAH + C-176 group (Fig. [8](#Fig8){ref-type="fig"}a-h). Immunofluorescence staining indicated that compound C reversed the effect of C-176 in alleviating neuronal injury (Fig. [8](#Fig8){ref-type="fig"}i, j). More importantly, blockade of AMPK signal with compound C abolished the beneficial effect of C-176 in attenuating neurological impairment (Fig. [8](#Fig8){ref-type="fig"}l, m). These data demonstrated a critical role of AMPK signal in C-176-mediated anti-inflammatory effect under SAH condition. Fig. 8Pharmacological inhibition of AMPK with compound C abolished the neuroprotective effect of C-176 against SAH at 24 h post-modeling. **a-h** Representative western blotting images and quantitative analyses of TBK1 phosphorylation, AMPK phosphorylation, and the expression of iNOS, cleaved IL-1β, NLRP3, ASC, and caspase-1 p20 at 24 h after SAH. *n* = 6. **i**, **j** Representative microphotographs and quantitative analysis of TUNEL assay. *n* = 6. **k** Relative mRNA level of M1 microglia markers genes (CD16, iNOS, IL-1β, IL-6, TNF-α, and MCP-1). *n* = 6. **l**, **m** The quantification of neurological function. *n* = 18. Data were represented as mean ± SD. \**P* \< 0.05 versus sham group. \#*P* \< 0.05 versus SAH + vehicle1 group. &*P* \< 0.05 versus SAH + C-176 group

Effect and mechanism studies in vitro {#Sec30}
-------------------------------------

The cultured BV2 cells were incubated with OxyHb to simulate the SAH insult in vitro. And the results of the cell viability assay indicated that neither C-176 or CMA per se could cause significant damage to cells in vitro (Supplementary Figure S[3](#MOESM5){ref-type="media"}). And consistent with the results in vivo, data from RT-PCR indicated that C-176 significantly decreased the mRNA level of microglial M1 markers, which were increased by OxyHb (Fig. [9](#Fig9){ref-type="fig"}a). Additionally, western blotting further confirmed that the phosphorylation of AMPK was upregulated by C-176 in vitro, accompanied by the decreased expression of pro-inflammation mediator iNOS, NLRP3, ASC, cleaved caspase-1, and IL-1β. However, C-176-mediated anti-inflammatory effect was reversed by compound C in vitro (Fig. [9](#Fig9){ref-type="fig"}). Fig. 9Effect and mechanism studies using a SAH model in vitro. **a** Quantification of RT-PCR on the relative mRNA level of M1 microglia markers genes (CD16, iNOS, IL-1β, IL-6, TNF-α, and MCP-1). **b** Representative western blotting images and quantitative analyses of TBK1 phosphorylation, AMPK phosphorylation, and the expression of iNOS, cleaved IL-1β, NLRP3, ASC, and caspase-1 p20. Data were represented as mean ± SD. \**P* \< 0.05 versus control group. \#*P* \< 0.05 versus OxyHb+vehicle group. &*P* \< 0.05 versus OxyHb +C-176 group

Discussion {#Sec31}
==========

In the current study, we investigated the role of STING in the pathological process following SAH and explored the relevant mechanisms. And we made the following major founds: (1) The expression level of STING was significantly increased and peaked at 24 h after SAH. (2) STING was mainly located in microglia. (3) Activation of STING-aggravated SAH-induced brain edema, neuronal damage, and exacerbated short-term and persistent neurological deficits, whereas inhibition of STING significantly alleviated SAH-induced brain injury. (4) STING-mediated neuroinflammation by promoting microglial activation and polarizing into M1 phenotype, and STING antagonist C-176 conferred a robust anti-inflammatory effect after SAH. (5) Blockage of AMPK signal reversed C-176 mediated anti-inflammatory effects against SAH both in vivo and in vitro. Based on the evidence above, STING contributes to robust inflammatory injury by enhancing microglia-mediated neuroinflammation after SAH. And pharmacological inhibition STING significantly alleviated SAH-induced inflammatory response, the anti-inflammatory effect of STING inhibition was at least partly mediated by AMPK signal (Fig. [10](#Fig10){ref-type="fig"}). Fig. 10Schematic mechanism of microglial STING regulates SAH-induced neuroinflammation. SAH insult activated microglial STING. Upon activated, STING phosphorylate, and activate TBK1, which subsequently inhibit the activity of AMPK, resulting microglial activation and polarize into M1 phenotype, accompanied by the secreting of pro-inflammatory mediators and damage to neuron. Pharmacological inhibition of STING with C-176 could attenuate SAH-induced inflammatory injury

STING is a transmembrane protein initially present in the endoplasmic reticulum (ER) that functions as an important intracellular signaling molecule via sensing pathogens and modulating innate immunity. Generally, intracellular cyclic DNA, which comes from pathogenic entities or leaked from damaged cell, can be cyclic recognizes and catalyze into cyclic dinucleotide cGAMP by GMP-AMP synthase (cGAS). Then, STING can be triggered by cGAMP directly and translocate from the ER to the ER-Golgi intermediate complex through the Golgi apparatus. TANK-binding kinase 1 (TBK1) is phosphorylated when it binds to the activated STING. Subsequently, the STING-TBK1 complex moves to perinuclear vesicle region and phosphorylates transcription factor IRF3, which further translocates into the nucleus and induces the expression of target genes, including type I interferon, and mediates innate immune response. The beneficial effect of STING signal in host defense has been studied for years as activation of STING is required for the clearance of multiple viruses such as influenza, herpesvirus, and hepatitis B virus (HBV), as well as bacteria \[[@CR15], [@CR16], [@CR33]--[@CR35]\]. In addition, recent studies have revealed the important role of STING in tumor immunity. Miao et al. demonstrated that STING confers a robust anti-tumor efficacy by recruiting CD8+ T cell and inhibiting tumor growth, eventually prolonging survival in melanoma and human papillomavirus E7 \[[@CR36]\]. Moreover, activation of STING could activate MHCII tumor-associated macrophages, resulting in tumor regression in mammary tumors \[[@CR37]\]. Notably, aberrant activation of STING signal was proven to contribute to tissue injury. Qiao et al. reported that excessive activation of STING in the liver was associated with the progression of nonalcoholic fatty liver disease through enhancing macrophage-mediated hepatic inflammation and fibrosis \[[@CR38]\]. Additionally, STING was identified as an important initiator that mediates silicosis-induced lung inflammatory injury \[[@CR39]\]. Despite of the pathophysiological roles of STING have been studied for years, little is known about the role of STING in the pathological process following SAH.

Therefore, in the first part of this study, we investigated the expression pattern of STING under SAH condition. Western blotting indicated that the level of STING was elevated after SAH, similar to a previous study that reported an upregulated level of STING after traumatic brain injury \[[@CR40]\]. Moreover, immunofluorescence staining further confirmed that STING was mainly distributed in microglia rather than neurons or astrocytes after SAH. Upon identifying the upregulated expression of STING, we further explored the role of STING in the pathological process of SAH. TBK1 is the direct downstream substrate that can be phosphorylated and activated by STING \[[@CR16]\]. Western blotting indicated that the level of TBK1 phosphorylation significantly increased after SAH, which can be explained by the upregulated expression of STING. And consistent with a previous study \[[@CR21]\], we found that C-176 significantly decreased the phosphorylation of TBK1, while CMA upregulated the ratio of p-TBK1/TBK1, suggesting the efficacy of the STING covalent inhibitor and activator under SAH condition in vivo. In addition, we observed a remarkable increased brain water content, suggesting that animals suffered from a serious brain edema after SAH as reported \[[@CR41]\]. And pharmacological inhibition of STING with C-176 significantly reduced brain water content. Additionally, C-176 significantly attenuated both short-term and persistent neurological dysfunction, as well as alleviated neuronal injury. Meanwhile, we found that activation of STING with CMA exacerbated brain edema, neuronal injury, and neurological disorder. All of the above data suggest that activation of STING aggravated SAH-induced brain injury, while pharmacological inhibition of STING conferred a neuroprotective effect against SAH, but the exact mechanism remains unknown.

Neuroinflammation, which is mediated by the activation of local microglia and recruitment of circulating immune cells such as neutrophils and macrophages, is one of the key drivers of secondary injury following SAH \[[@CR42]\]. Previous studies including ours indicated that suppressing neuroinflammation confers a significant improvement in neurological outcome after SAH \[[@CR27], [@CR41], [@CR43]\]. Microglia is the resident macrophage distributed in CNS that can be rapidly activated in response to pathological changes, including hypoxia, acidity, infection, or brain tissue injury and play a critical role in mediating neuroinflammation \[[@CR5]\]. Recent studies indicated that activated microglia can be generally divided into M1 phenotype and the M2 phenotype with different biological functions \[[@CR8]\]. The M1 phenotype microglia can directly attack to neurons and change microenvironment via releasing neurotoxicity factors such as IL-1β or recruiting other neurotoxicity cells such as A1 astrocyte and macrophages, resulting in an amplification of inflammatory response and exacerbating the brain damage \[[@CR44]\]. The aberrant activation of microglia has been proven to participate in the pathological process of multiple CNS diseases including traumatic brain injury, Alzheimer's disease, ischemic stroke, and SAH \[[@CR10], [@CR45]--[@CR47]\]. Meanwhile, the M2 phenotype microglia were identified to release anti-inflammatory and neuroprotective effects via secreting anti-inflammatory cytokines and promoting neural regeneration, oligodendrogenesis, and angiogenesis \[[@CR48]\]. Notably, recent studies demonstrated that activation of STING could repolarize macrophages from M2 phenotype into M1 phenotype in a disease model of tuberculosis infection and colitis \[[@CR49], [@CR50]\].

Nucleotide-binding oligomerization domain-like (NOD-like) receptor containing pyrin domain 3 (NLRP3) inflammasome, which is composed of NLRP3 protein, apoptosis-associated speck-like protein containing a caspase recruitment domain (ASC) and pro-caspase-1, has been proposed as a crucial mediator of innate immunity via responding to multiple microbial infections and cellular damage. Upon sensing the danger signal, the NLRP3 protein can recruit the adapter ASC, which further recruits and cleaved pro-caspase-1. Ultimately, the activated caspase-1 could cleave pro-IL-1β into its mature and biologically active form, resulting in the activation of subsequent inflammatory response \[[@CR51], [@CR52]\]. Notably, the NLRP3 inflammasome has also been proposed as a critical mediator of microglial M1 polarization. Xu et al. reported that NLRP3 inflammasome could polarize microglia into M1 phenotype and exacerbate ischemia-induced brain injury \[[@CR9]\]. In contrast, inhibition of NLRP3 inflammasome confers a significant neuroprotection via reprogramming microglia into M2 phenotype from M1 phenotype \[[@CR53], [@CR54]\]. Furthermore, recent studies indicated that STING could regulate the activation of NLRP3 inflammasome in human myeloid cells and cardiomyocyte \[[@CR55], [@CR56]\]. However, the exact effect of STING on neuroinflammation under SAH condition remains unintelligible. Given the essential role of STING in regulating macrophage polarization and the robustly upregulated expression of STING observed in microglia, an important participant for innate immunity, after SAH, we hypothesize that STING acts as an important regulator that mediate neuroinflammation after SAH.

Therefore, we explored the effect of STING on SAH-induced neuroinflammation in the next part of this study. We found that microglia were significantly activated and polarized into M1 phenotype after SAH, as evidenced by the morphological changes and increased level of microglial M1 markers CD16, IL-1β, iNOS, IL-6, TNF-α, and NLRP3 inflammasome. Similar to previous literature demonstrating the effect of STING in modulating macrophage polarization \[[@CR49], [@CR50]\], our data indicated that activation of STING could enhance inflammatory response through promoting microglial activation and polarizing into pro-inflammatory M1 phenotype. And treatment with C-176 significantly inhibited STING-mediated neuroinflammation after SAH. These data suggested a critical role of STING in mediating neuroinflammation after SAH. And pharmacological inhibition of STING could confer a robust neuroprotective effect against SAH by attenuating inflammatory injury.

In the rest part of this study, we further investigated the potential molecular mechanism of C-176 in mediating anti-inflammatory effects under SAH condition. AMP-activated protein kinase (AMPK) is a heterotrimeric protein that functions as a key energy sensor and plays an important role in maintaining metabolism homeostasis by upregulating lipid oxidation and mitochondrial biogenesis \[[@CR57]\]. In addition, AMPK has also been identified to be an important regulator of autophagy through upregulating the activity of Unc-51-like autophagy-activating kinase 1 (ULK1) \[[@CR58]\]. Recently, the essential role of AMPK in modulating inflammatory response has also been confirmed. Sanchez et al. reported that activation of AMPK could potentiate mitochondrial recruitment of DRP1 and stimulates mitophagy, resulting in the termination of NLRP3 inflammasome activation \[[@CR59]\]. Moreover, the anti-inflammatory effect of AMPK has also been proven in multiple disease models, including temporomandibular joint osteoarthritis, synovial tissue inflammation, and in myocardial ischemia-reperfusion injury \[[@CR60]--[@CR62]\]. More importantly, a recent study indicated that AMPK is a downstream of the substrate of STING-TBK1 complex, and suppression of AMPK by TBK1 significantly enhanced the inflammatory response both in vivo and in vitro \[[@CR32]\].

Based on the evidence above, we further investigated the role of AMPK in C-176-mediated anti-inflammatory effects after SAH. Consistent with the previous study \[[@CR28]\], an increased ratio of p-AMPK/AMPK after SAH was noted in this study. And we found that C-176 further promoted the phosphorylation of AMPK, which can be explained by the elimination of the negative impact of TBK1 on AMPK as reported \[[@CR32]\]. Furthermore, similar to previous studies revealing the beneficial effects of AMPK in TBI and MACO \[[@CR63], [@CR64]\], we noted that the upregulation of AMPK activity, which was induced by C-176, was accompanied with decreased microglial M1 polarization (as evidenced by the decreased level of pro-inflammatory chemokine and the inhibition of NLRP3 inflammasome), reduced neuronal damage, and significant improvement in neurological function. However, blockade of AMPK with compound C abolished all the neuroprotective effects of C-176 against SAH. Moreover, the critical role of AMPK signal in C-176-mediated anti-inflammatory effects was also confirmed by the data from an SAH model in vitro. All of the above evidence indicated that STING aggravates neuroinflammation after SAH. And pharmacological inhibition of STING could alleviate SAH-induced inflammatory injury, which was, at least partly mediated by the AMPK signal.

Several limitations of the current study should not be ignored. First, AMPK has been proven to confer neuroprotective effects against CNS disease through multiple mechanisms, such as regulating autophagy, cell metabolism, and proteostasis. We focused on only AMPK-mediated anti-inflammatory effects in the current study. Second, although the mechanism by which STING signal downregulates the AMPK activity was previously identified in adipose tissue, the exact interaction between microglial STING activation and AMPK inhibition under SAH condition has not been studied. Third, we focused on the role of STING in regulating microglia-mediated neuroinflammation after SAH in this study. However, whether STING mediates neuroinflammatory injury through regulating another immune cells, such as T lymphocyte and macrophages, both of which contribute to CNS homeostasis, has not been determined. Additionally, neuro-regeneration is an important physical process that influences the outcome of multiple CNS disease. However, the effect STING in regenerative processes has not been determined in this study. Therefore, more efforts are required to further explore the potential role of STING in another mechanism beyond inflammation and to determine the effect of STING in other types of immune cells and regenerative processes after SAH in the future.

Conclusion {#Sec32}
==========

The current study investigated the role and mechanism of STING in the pathophysiological process after SAH. Our data indicated that STING contributes to SAH-induced neuroinflammation by promoting microglial activation and polarizing into M1 phenotype. Furthermore, pharmacological inhibition of STING could attenuate inflammatory injury via AMPK-related anti-inflammatory signal under SAH condition. Altogether, the current study supports the notion that targeting STING might be a novel and promising therapeutic strategy for SAH.
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**Additional file 1: Supplementary Table S1.** Information of primers used for RT-PCR. **Additional file 2: Supplementary Table S2.** Experimental design and animals assigned per group. **Additional file 3: Supplementary Figure S1.** Quantification of STING-positive cells at 24 h after SAH. The number of STING significantly increased after SAH. Furthermore, both in sham group and in SAH group, STING (red) is co-located with microglia (Iba-1, green), rather than neurons (NeuN, green) or astrocytes (GFAP, green). Data was represented as mean ± SD. \**P* \< 0.05 versus sham group. **Additional file 4: Supplementary Figure S2.** Effect of C-176 and CMA on TBK1 phosphorylation, brain edema and neurological function at 24 h post-modeling. **a** Representative picture and quantitative analysis of phosphorylation level of TBK1, a direct substrate of STING, in sham groups and in SAH groups. n = 6. **b** Quantification of brain water content among different groups. n = 6. **c,d** The quantification of neurological function with two different grade system. n = 12 for sham+C-176 group and sham+CMA group, while n = 24 for another groups. Data was represented as mean ± SD. \*P \< 0.05 versus sham group. \#P \< 0.05 versus SAH + vehicle group. **Additional file 5: Supplementary Figure S3.** Effect of C-176 and CMA on the viability of BV2 cells. \**P* \< 0.05 versus control group.
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